Inventor · disambiguated record
Benjamin Frydman
Also filed as: CLIFFORD LEGAL REPRESENTATIVE · CLIFFORD LINDA · FRYDMAN BENJAMIN · FRYDMAN BENJAMIN J
21 granted patents·11 pending applications·618 citations·filing 1995–2009
97Inventor score
Files withWISCONSIN ALUMNI RES FOUND8CELLGATE INC7SLIL BIOMEDICAL CORP7FRYDMAN BENJAMIN4PROGEN PHARMACEUTICALS INC3
Top patents by PatentIndex Score
32 records- 0194US6982351B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforCELLGATE INC·Filed 2002·Granted Jan 3, 2006·38 cites·11 claims
- 0293US6809176B2Quinones as disease therapiesSLIL BIOMEDICAL CORP·Filed 2002·Granted Oct 26, 2004·40 cites·8 claims
- 0393US5763625ASynthesis and use of β-lapachone analogsWISCONSIN ALUMNI RES FOUND·Filed 1995·Granted Jun 9, 1998·71 cites·32 claims
- 0492US7453011B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforPROGEN PHARMACEUTICALS INC·Filed 2007·Granted Nov 18, 2008·17 cites·14 claims
- 0592US7312244B2Polyamine analog-amino acid conjugates useful as anticancer agentsCELLGATE INC·Filed 2001·Granted Dec 25, 2007·28 cites·24 claims
- 0691US7279502B2Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesCELLGATE INC·Filed 2004·Granted Oct 9, 2007·31 cites·6 claims
- 0791US7235695B2Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis thereforFRYDMAN BENJAMIN·Filed 2005·Granted Jun 26, 2007·17 cites·26 claims
- 0891US6482943B1Quinones as disease therapiesSLIL BIOMEDICAL CORP·Filed 2000·Granted Nov 19, 2002·26 cites·1 claims
- 0990US6649587B1Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesSLIL BIOMEDICAL CORP·Filed 2000·Granted Nov 18, 2003·27 cites·20 claims
- 1090US5889061AConformationally restricted polyaminesWISCONSIN ALUMNI RES FOUND·Filed 1997·Granted Mar 30, 1999·48 cites·24 claims
- 1186US6392098B1Conformationally restricted polyaminesWISCONSIN ALUMNI RES FOUND·Filed 1999·Granted May 21, 2002·28 cites·22 claims
- 1285US6794545B1Conformationally restricted polyamine analogs as disease therapiesSLIL BIOMEDICAL CORP·Filed 2000·Granted Sep 21, 2004·20 cites·20 claims
- 1384US7253207B2Quinones as disease therapiesCELLGATE INC·Filed 2004·Granted Aug 7, 2007·11 cites·21 claims
- 1484US7186825B2Conformationally restricted polyamine analogs as disease therapiesCELLGATE INC·Filed 2004·Granted Mar 6, 2007·15 cites·20 claims
- 1584US5969163AOrtho-quinone derivatives, novel synthesis therefor, and their use in the inhibition of neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 1997·Granted Oct 19, 1999·71 cites·18 claims
- 1683US7026347B2Porphyrin-polyamine conjugates for cancer therapyCELLGATE INC·Filed 2003·Granted Apr 11, 2006·14 cites·16 claims
- 1782US5824700AOrtho-quinone derivatives novel synthesis therefor and their use in the inhibition of neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 1996·Granted Oct 20, 1998·59 cites·7 claims
- 1876US5883270A4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 1996·Granted Mar 16, 1999·16 cites·1 claims
- 1968US5677350AInhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanesWISCONSIN ALUMNI RES FOUND·Filed 1995·Granted Oct 14, 1997·31 cites·18 claims
- 2065US5977187A4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growthWISCONSIN ALUMNI RES FOUND·Filed 1998·Granted Nov 2, 1999·9 cites·10 claims
- 2164US2009275664A1Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesFRYDMAN BENJAMIN·Filed 2009·Application pending·0 cites
- 2260US2009124832A1Oligoamine compounds and derivatives thereof for cancer therapyPROGEN PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2359US2008194697A1Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesFRYDMAN BENJAMIN·Filed 2007·Application pending·0 cites
- 2457US2007161692A1Conformationally restricted polyamine analogs as disease therapiesCELLGATE INC·Filed 2006·Application pending·0 cites
- 2556US7491849B2Oligoamine compounds and derivatives thereof for cancer therapyPROGEN PHARMACEUTICALS INC·Filed 2004·Granted Feb 17, 2009·1 cites·21 claims
- 2654US2004006049A1Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseasesSLIL BIOMEDICAL CORP·Filed 2003·Application pending·0 cites
- 2746US2006276444A1Porphyrin-polyamine conjugates for cancer therapyFRYDMAN BENJAMIN·Filed 2006·Application pending·0 cites
- 2846US2003130356A1Oligoamine compounds and derivatives thereof for cancer therapySLIL BIOMEDICAL CORP·Filed 2002·Application pending·0 cites
- 2945US2005130949A1Cyclic polyamine compounds for cancer therapyFiled 2005·Application pending·0 cites
- 3044US2004192665A1Conjugates of porphyrin compounds with chemotherapeutic agentsSLIL BIOMEDICAL CORP·Filed 2003·Application pending·0 cites
- 3143US2009143456A1Polyamine Analogs as Modulators of Cell Migration and Cell MotilityMARTON LAURENCE J·Filed 2006·Application pending·0 cites
- 3236US2003072715A1Cyclic polyamine compounds for cancer therapyFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benjamin Frydman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →